As a result, Trenbolone Acetate now functions as the primary anabolic compound (aka the ‘workhorse’ compound) that will function to provide the muscle growth throughout the cycle. Trenbolone is strictly an advanced level anabolic steroid, unfit for use by beginners of any type. In this cycle, the Acetate variant of Trenbolone is utilized simply due to its seamless compatibility with Testosterone Propionate. This is because the Propionate and Acetate esters as, previously mentioned early on in this section of the profile, both possess almost identical half-lives (3 days for Trenbolone Acetate and days for Testosterone Propionate). This therefore provides an ease of convenience for the user, as well as smoother injection and administration frequencies. The fact that Testosterone is being utilized at a low enough doses to avoid aromatization, combined with the fact that Trenbolone’s inability to convert into Estrogen at any dose should result in the total elimination of any potential water retention, bloating, gynecomastia or any side effects associated with Estrogen . It is important to note that this cycle in particular is strong enough to be utilized as a bulking cycle, lean mass cycle, or cutting cycle – all without the inflated potential for water retention or other Estrogenic side effects .
Select Your State (*) : Select Your State Alabama Alaska Arizona Arkansas California Canada Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Puerto Rico Rhode Island South Carolina South Dakota Tennessee Texas Utah . Virgin Islands Vermont Virginia Washington Washington,DC West Virginia Wisconsin Wyoming
In androgen-responsive target tissues such as the skin, scalp, and prostate, the high relative androgenicity of testosterone is dependant on its reduction to dihydrotestosterone (DHT). The 5-alpha reductase enzyme is responsible for this metabolism of testosterone. The concurrent use of a 5-alpha reductase inhibitor such as finasteride or dutasteride will interfere with site-specific potentiation of testosterone action, lowering the tendency of testosterone drugs to produce androgenic side effects. It is important to remember that both anabolic and androgenic effects are mediated via the cytosolic androgen receptor. Complete separation of testosterone’s anabolic and androgenic properties is not possible, even with total 5-alpha reductase inhibition.